Craft

Teligent

Stock Price

$0

2021-11-10

Market Capitalization

$16.1 M

2021-11-10

Revenue

$45.3 M

FY, 2020

Teligent Summary

Company Summary

Overview
Teligent is a specialty generic pharmaceutical company which develops, formulates, manufactures, and markets generic topical, branded generic, and generic injectable pharmaceutical products. The Company sells generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms. It also develops, manufactures, fills, and packages topical semi-solid and liquid products for branded and generic pharmaceutical customers, as well as for over-the-counter and cosmetic markets. The Company's products are used in various applications that range from cosmetics and cosmeceuticals to the prescription treatment of conditions, such as dermatitis, psoriasis, and eczema. In addition, it offers contract formulation and contract manufacturing services.
Type
Public
Status
Active
Founded
1977
HQ
Vineland, NJ, US | view all locations
Website
http://www.teligent.com/
Cybersecurity rating
ESG rating
30-39 out of 100|View all ESG data
Sectors

Key People

  • Tim Sawyer

    Tim Sawyer, President & CEO

    • Tyler Barnes

      Tyler Barnes, Commercial Operations Lead, Global Demand & CMO Relations

      • Steven Pinsky

        Steven Pinsky, Acting CFO

        • Philip Yachmetz

          Philip Yachmetz, EVP, Chief Legal Officer & Secretary

          LocationsView all

          4 locations detected

          • Vineland, NJ HQ

            United States

            105 Lincoln Ave

          • Woodbridge Township, NJ

            United States

            33 S Wood Ave #730, Iselin

          • Mississauga, ON

            Canada

            5995 Avebury Rd #804

          • Tallinn, Harju maakond

            Estonia

            Akadeemia tee 21/5

          Teligent Financials

          Summary Financials

          Revenue (Q2, 2021)
          $10.4M
          Gross profit (Q2, 2021)
          ($2.7M)
          Net income (Q2, 2021)
          ($12.9M)
          Cash (Q2, 2021)
          $22.6M
          EBIT (Q2, 2021)
          ($10.7M)
          Enterprise value
          $18.5M

          Footer menu